Skip to main content

U.S. Pharmaceutical Sales - Q3 2012

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q3 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 drugs for Q3 2012 by sales

Rank Drug Sales ($000)
1 Nexium
AstraZeneca
2.93% Stats
2 Abilify
Otsuka Pharmaceutical Co., Ltd
1.89% Stats
3 (2) Crestor
AstraZeneca
10.74% Stats
4 (2) Cymbalta
9.50% Stats
5 (2) Humira
AbbVie Inc.
13.45% Stats
6 (2) Advair Diskus
GlaxoSmithKline
2.10% Stats
7 (1) Enbrel
Amgen Inc.
12.51% Stats
8 (2) Remicade
Janssen Pharmaceuticals, Inc.
2.02% Stats
9 (4) Copaxone
Teva Pharmaceuticals USA, Inc.
9.93% Stats
10 (1) Neulasta
Amgen Inc.
-1.17% Stats
11 (1) Rituxan
Genentech, Inc.
-5.61% Stats
12 (4) Atripla
Gilead Sciences, Inc.
1.34% Stats
13 (2) OxyContin
Purdue Pharma LP
-0.55% Stats
14 (3) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
1.31% Stats
15 (4) Januvia
Merck
7.50% Stats
16 (2) Avastin
Genentech, Inc.
0.41% Stats
17 (7) Lantus
Sanofi
4.94% Stats
18 (5) Truvada
Gilead Sciences, Inc.
1.56% Stats
19 (7) Lantus Solostar
Sanofi
11.36% Stats
20 (2) Epogen
Amgen Inc.
-5.18% Stats
21 (7) Lyrica
9.94% Stats
22 (9) Celebrex
12.77% Stats
23 (20) Singulair
Merck
-62.20% Stats
24 (1) Diovan
Novartis Pharmaceuticals Corporation
-4.29% Stats
25 (9) Gleevec
Novartis Pharmaceuticals Corporation
10.57% Stats
26 (4) Herceptin
Genentech, Inc.
-0.84% Stats
27 (8) Namenda
Allergan plc
6.05% Stats
28 (14) Suboxone
14.63% Stats
29 (4) Avonex
Biogen
-5.34% Stats
30 (3) enoxaparin
Generic
-15.96% Stats
31 (6) Lucentis
Genentech, Inc.
-1.88% Stats
32 escitalopram
Generic
-8.48% Stats
33 (6) OneTouch
3.43% Stats
34 (2) Diovan HCT
Novartis Pharmaceuticals Corporation
-7.39% Stats
35 (3) Vyvanse
Takeda Pharmaceutical Company Limited
-2.81% Stats
36 (7) Zetia
Merck
7.06% Stats
37 (7) AndroGel
AbbVie Inc.
6.38% Stats
38 (3) methylphenidate
Generic
0.01% Stats
39 (18) Actos
Takeda Pharmaceutical Company Limited
-41.96% Stats
40 (5) Lidoderm
Endo Pharmaceuticals Inc.
6.92% Stats
41 (7) TriCor
AbbVie Inc.
6.40% Stats
42 (7) Rebif
EMD Serono, Inc.
8.88% Stats
43 (3) Symbicort
AstraZeneca
4.37% Stats
44 (10) Novolog
Novo Nordisk
8.83% Stats
45 (5) Incivek
Vertex Pharmaceuticals Incorporated
-18.72% Stats
46 (9) Seroquel XR
AstraZeneca
6.05% Stats
47 (3) Alimta
Eli Lilly and Company
-1.39% Stats
48 (8) Viagra
7.82% Stats
49 (8) Levemir
Novo Nordisk
7.66% Stats
50 (1) amphetamine/dextroamphetamine
Generic
-0.97% Stats
51 (12) NovoLog FlexPen
Novo Nordisk
11.89% Stats
52 (12) ProAir HFA
Teva Pharmaceuticals USA, Inc.
12.06% Stats
53 (7) Lovaza
GlaxoSmithKline
8.82% Stats
54 (1) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc.
-1.79% Stats
55 (22) Varivax
Merck
31.34% Stats
56 (3) Niaspan
AbbVie Inc.
4.70% Stats
57 (10) Procrit
Janssen Pharmaceuticals, Inc.
-10.20% Stats
58 (8) Humalog
Eli Lilly and Company
8.03% Stats
59 (1) metoprolol
Generic
-0.87% Stats
60 (2) Neupogen
Amgen Inc.
2.65% Stats
61 (9) Nasonex
Merck
-9.30% Stats
62 (1) Flovent HFA
GlaxoSmithKline
-2.46% Stats
63 (2) Reyataz
Bristol-Myers Squibb Company
1.20% Stats
64 (4) Isentress
Merck
2.58% Stats
65 (6) Vytorin
Merck
6.33% Stats
66 (1) modafinil
Generic
-0.79% Stats
67 (3) Janumet
Merck
5.21% Stats
68 (5) Cialis
Eli Lilly and Company
9.05% Stats
69 (14) acetaminophen/hydrocodone
Generic
18.96% Stats
70 (17) Gilenya
Novartis Pharmaceuticals Corporation
21.19% Stats
71 (2) Aranesp
Amgen Inc.
-1.51% Stats
72 (3) Restasis
Allergan plc
7.35% Stats
73 (6) Aciphex
Eisai Inc.
10.07% Stats
74 (24) Victoza
Novo Nordisk
27.22% Stats
75 (1) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
3.84% Stats
76 (6) Orencia
Bristol-Myers Squibb Company
6.17% Stats
77 (11) Betaseron
Bayer HealthCare Pharmaceuticals Inc.
11.98% Stats
78 (49) Eloxatin
Sanofi
-55.33% Stats
79 (7) VESIcare
Astellas Pharma US, Inc.
9.64% Stats
80 (10) Dexilant
Takeda Pharmaceutical Company Limited
13.25% Stats
81 (9) Adderall XR
Takeda Pharmaceutical Company Limited
-7.81% Stats
82 (4) fentanyl
Generic
-0.39% Stats
83 (3) Prezista
Janssen Pharmaceuticals, Inc.
1.17% Stats
84 () Zostavax
Merck
n/a Stats
85 (7) Evista
9.53% Stats
86 (7) Benicar
Daiichi Sankyo
9.67% Stats
87 () Gardasil
Merck
n/a Stats
88 (68) Lipitor
-67.80% Stats
89 (8) budesonide
Generic
-3.36% Stats
90 (7) Synthroid
AbbVie Inc.
12.61% Stats
91 () Xolair
n/a Stats
92 (2) Renvela
Sanofi
7.39% Stats
93 (4) Lunesta
Sunovion Pharmaceuticals Inc.
2.23% Stats
94 (10) Prevnar 13
Pfizer Inc.
-5.86% Stats
95 (1) Xeloda
Genentech, Inc.
5.28% Stats
96 () EpiPen 2-Pak
n/a Stats
97 () Sensipar
Amgen Inc.
n/a Stats
98 (7) Zyvox
Pfizer Inc.
-1.37% Stats
99 (85) atorvastatin
Generic
-78.25% Stats
100 () Stelara
Janssen Pharmaceuticals, Inc.
n/a Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.